These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
445 related items for PubMed ID: 21751518
1. [Metabolic assessment of hydrocortisone replacement therapy in patients with primary adrenocortical insufficiency]. Fichna M, Gryczyńska M, Sowińska A, Sowiński J. Przegl Lek; 2011; 68(2):96-102. PubMed ID: 21751518 [Abstract] [Full Text] [Related]
2. Bone mineral density is reduced in female but not male subjects with Addison's disease. Florkowski CM, Holmes SJ, Elliot JR, Donald RA, Espiner EA. N Z Med J; 1994 Feb 23; 107(972):52-3. PubMed ID: 8115069 [Abstract] [Full Text] [Related]
3. Salivary cortisol day curves in Addison's disease in patients on hydrocortisone replacement. Ross IL, Levitt NS, Van der Walt JS, Schatz DA, Johannsson G, Haarburger DH, Pillay TS. Horm Metab Res; 2013 Jan 23; 45(1):62-8. PubMed ID: 22893258 [Abstract] [Full Text] [Related]
4. Bone mineral density in patients with treated Addison's disease. Braatvedt GD, Joyce M, Evans M, Clearwater J, Reid IR. Osteoporos Int; 1999 Jan 23; 10(6):435-40. PubMed ID: 10663342 [Abstract] [Full Text] [Related]
5. Vertebral fractures assessed with dual-energy X-ray absorptiometry in patients with Addison's disease on glucocorticoid and mineralocorticoid replacement therapy. Camozzi V, Betterle C, Frigo AC, Zaccariotto V, Zaninotto M, De Caneva E, Lucato P, Gomiero W, Garelli S, Sabbadin C, Salvà M, Costa MD, Boscaro M, Luisetto G. Endocrine; 2018 Feb 23; 59(2):319-329. PubMed ID: 28795340 [Abstract] [Full Text] [Related]
6. [Evaluation of corticosteroid replacement therapy and its effect on bones in Addison's disease]. Heureux F, Maiter D, Boutsen Y, Devogelaer JP, Jamart J, Donckier J. Ann Endocrinol (Paris); 2000 Sep 23; 61(3):179-83. PubMed ID: 10970940 [Abstract] [Full Text] [Related]
7. Variable sensitivity to the glucocorticoid activity of cortisol in patients with primary adrenal insufficiency: assessment with ACTH profiles. Ekman B, Blomgren J, Andersson PO, Carlsson M, Arnqvist HJ. Horm Metab Res; 2010 Dec 23; 42(13):961-6. PubMed ID: 20925018 [Abstract] [Full Text] [Related]
8. [Addison's disease : Primary adrenal insufficiency]. Pulzer A, Burger-Stritt S, Hahner S. Internist (Berl); 2016 May 23; 57(5):457-69. PubMed ID: 27129928 [Abstract] [Full Text] [Related]
9. [Introduction: Patients with primary adrenal insufficiency receive long - term glucocorticoid replacement therapy, which may cause osteoporosis]. Vaňuga P, Ságová I. Vnitr Lek; 2021 May 23; 67(5):264-269. PubMed ID: 35459392 [Abstract] [Full Text] [Related]
10. Increased serum osteoprotegerin in patients with primary adrenal insufficiency receiving conventional hydrocortisone substitution. Fichna M, Zurawek M, Fichna P, Gryczynska M, Nowak J, Ruchala M. J Physiol Pharmacol; 2012 Dec 23; 63(6):677-82. PubMed ID: 23388484 [Abstract] [Full Text] [Related]
11. Circadian hydrocortisone infusions in patients with adrenal insufficiency and congenital adrenal hyperplasia. Merza Z, Rostami-Hodjegan A, Memmott A, Doane A, Ibbotson V, Newell-Price J, Tucker GT, Ross RJ. Clin Endocrinol (Oxf); 2006 Jul 23; 65(1):45-50. PubMed ID: 16817818 [Abstract] [Full Text] [Related]
12. Improvement of anthropometric and metabolic parameters, and quality of life following treatment with dual-release hydrocortisone in patients with Addison's disease. Giordano R, Guaraldi F, Marinazzo E, Fumarola F, Rampino A, Berardelli R, Karamouzis I, Lucchiari M, Manetta T, Mengozzi G, Arvat E, Ghigo E. Endocrine; 2016 Feb 23; 51(2):360-8. PubMed ID: 26184416 [Abstract] [Full Text] [Related]
13. Addison's disease, diffuse skin, and mucosal hyperpigmenation with subtle "flu-like" symptoms--a report of two cases. Burk CJ, Ciocca G, Heath CR, Duarte A, Dohil M, Connelly EA. Pediatr Dermatol; 2008 Feb 23; 25(2):215-8. PubMed ID: 18429783 [Abstract] [Full Text] [Related]
14. Glucocorticoid replacement therapy and pharmacogenetics in Addison's disease: effects on bone. Løvås K, Gjesdal CG, Christensen M, Wolff AB, Almås B, Svartberg J, Fougner KJ, Syversen U, Bollerslev J, Falch JA, Hunt PJ, Chatterjee VK, Husebye ES. Eur J Endocrinol; 2009 Jun 23; 160(6):993-1002. PubMed ID: 19282465 [Abstract] [Full Text] [Related]
15. Addison's disease in pregnancy: Case report, management, and review of the literature. Margulies SL, Corrigan K, Bathgate S, Macri C. J Neonatal Perinatal Med; 2020 Jun 23; 13(2):275-278. PubMed ID: 31744021 [Abstract] [Full Text] [Related]
16. Bone mineral density is not significantly reduced in adult patients on low-dose glucocorticoid replacement therapy. Koetz KR, Ventz M, Diederich S, Quinkler M. J Clin Endocrinol Metab; 2012 Jan 23; 97(1):85-92. PubMed ID: 21994966 [Abstract] [Full Text] [Related]
17. [Evaluation of leptin levels in plasma and their reliance on other hormonal factors affecting tissue fat levels in people with various levels of endogenous cotisol]. Robaczyk MG. Ann Acad Med Stetin; 2002 Jan 23; 48():283-300. PubMed ID: 14601484 [Abstract] [Full Text] [Related]
18. Circadian hormone profiles and insulin sensitivity in patients with Addison's disease: a comparison of continuous subcutaneous hydrocortisone infusion with conventional glucocorticoid replacement therapy. Björnsdottir S, Øksnes M, Isaksson M, Methlie P, Nilsen RM, Hustad S, Kämpe O, Hulting AL, Husebye ES, Løvås K, Nyström T, Bensing S. Clin Endocrinol (Oxf); 2015 Jul 23; 83(1):28-35. PubMed ID: 25400085 [Abstract] [Full Text] [Related]
19. [Treatment of adrenal deficiency: To what issues? By which therapeutic means?]. Reznik Y. Presse Med; 2014 Apr 23; 43(4 Pt 1):438-43. PubMed ID: 24636680 [Abstract] [Full Text] [Related]
20. Studies on cortisol substitution therapy in patients with adrenal insufficiency. Nickelsen T, Schulz F, Demisch K. Exp Clin Endocrinol; 1983 Jul 23; 82(1):35-41. PubMed ID: 6311594 [Abstract] [Full Text] [Related] Page: [Next] [New Search]